Latest IPREX Stories
- iPrEx OLE is the first PrEP demonstration project to report on its experience; results presented as a late-breaker at AIDS 2014, published in Lancet Infectious Diseases - MELBOURNE,
The CDC’s Guidelines Expand the Pool of Patients Who Should Be Educated About PrEP Boston, MA (PRWEB) May 16, 2014
SAN FRANCISCO, March 6, 2014 /PRNewswire-USNewswire/ -- San Francisco AIDS Foundation has appointed Robert Grant, MD, MPH, as chief medical officer, with special focus on advancing the foundation's
In 2012 the HIV antiretroviral drug Truvada became the first and only medication approved by the FDA for HIV prevention.
- Large; stout; burly.